Evidence map›Paper›PMID 39947179›Full record

ArticleCell2025

ArfGAP2 promotes STING proton channel activity, cytokine transit, and autoinflammation.

Subhajit Poddar, Samuel D Chauvin, Christopher H Archer, Wei Qian, Jean A Castillo-Badillo, Xin Yin, W Miguel Disbennett, Cathrine A Miner, Joe A Holley, Teresa V Naismith and 23 more

Abstract read
In one paragraph

Article in Cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Compartmental pH regulation in cancer and antitumor immunity: therapeutic opportunities and challenges.Apoptosis : an international journal on programmed cell death · 2026
    Review
  6. Review
  7. Autoinflammatory syndromes of STING and TREX1 dysfunction.The Journal of clinical investigation · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer's disease treatment.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Subhajit PoddarDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Samuel D ChauvinDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Christopher H ArcherDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Wei QianDepartment of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Jean A Castillo-BadilloDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Xin YinImmunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
W Miguel DisbennettDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Cathrine A MinerDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Joe A HolleyDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Teresa V NaismithDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO 63110, USA.
W Alexander StinsonDepartment of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Xiaochao WeiDepartment of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Yue NingDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Jiayuan FuDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Trini A OchoaDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Nehalee SurveDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Shivam A ZaverDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Kimberly A WodzanowskiDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Katherine R BalkaDepartment of Biochemistry and Molecular Biology, Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Rajan VenkatramanDepartment of Biochemistry and Molecular Biology, Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Canyu LiuDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Kelly RomeDepartment of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Will BailisDepartment of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Yoko ShibaFaculty of Science and Engineering, Iwate University, Morioka 020-8551, Japan.
Sara CherryInstitute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Sunny ShinDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Clay F SemenkovichDepartment of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Dominic De NardoDepartment of Biochemistry and Molecular Biology, Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Sunnie YohImmunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Elisha D O RobersonDepartment of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St Louis, MO 63110, USA.
Sumit K ChandaImmunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
David J KastDepartment of Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO 63110, USA. Electronic address: kast@wustl.edu.
Jonathan J MinerDivision of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Colton Center for Autoimmunity, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: jonathan.miner@pennmedicine.upenn.edu.

Funding

University of Pennsylvania Postdoctoral Opportunities in Research and TeachingK12GM081259 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Janis K. Burkhardt · 2007 to 2026
$20.1M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Christine T. Pham · 2018 to 2026
$7.6M
Mechanisms of STING-associated immunodeficiencyR01AI143982 · NIAID · WASHINGTON UNIVERSITY · PI Jonathan J Miner · 2019 to 2026
$4.6M
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.R01AI177265 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SUMIT K CHANDA, Sunnie Yoh · 2023 to 2026
$3.4M
Role of TREX1 in age-related hereditary leukoencephalopathyR01NS131480 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Jonathan J Miner · 2023 to 2026
$3.2M
Stress-modified growth signaling in dynamic nutrient environmentsR35GM138085 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI Will H. Bailis · 2020 to 2026
$2.7M
Regulation of Lipid Droplet Biogenesis and LipophagyR01GM136925 · NIGMS · WASHINGTON UNIVERSITY · PI KAST, DAVID J · 2020 to 2024
$1.8M
NIAID NIH HHS R01 AI143982NIAID NIH HHS R01 AI177265NIAMS NIH HHS P30 AR073752NIGMS NIH HHS K12 GM081259NIGMS NIH HHS R01 GM136925NIGMS NIH HHS R35 GM138085NINDS NIH HHS R01 NS131480
6 · The paper itself

Abstract

Stimulator of interferon genes (STING) transmits signals downstream of the cytosolic DNA sensor cyclic guanosine monophosphate-AMP synthase (cGAS), leading to transcriptional upregulation of cytokines. However, components of the STING signaling pathway, such as IRF3 and IFNAR1, are not essential for autoinflammatory disease in STING gain-of-function (STING-associated vasculopathy with onset in infancy [SAVI]) mice. Recent discoveries revealed that STING also functions as a proton channel that deacidifies the Golgi apparatus. Because pH impacts Golgi enzyme activity, protein maturation, and trafficking, we hypothesized that STING proton channel activity influences multiple Golgi functions. Here, we show that STING-mediated proton efflux non-transcriptionally regulates Golgi trafficking of protein cargos. This process requires the Golgi-associated protein ArfGAP2, a cell-type-specific dual regulator of STING-mediated proton efflux and signaling. Deletion of ArfGAP2 in hematopoietic and endothelial cells markedly reduces STING-mediated cytokine and chemokine secretion, immune cell activation, and autoinflammatory pathology in SAVI mice. Thus, ArfGAP2 facilitates STING-mediated signaling and cytokine release in hematopoietic cells, significantly contributing to autoinflammatory disease pathogenesis.

Indexed as

CytokinesGTPase-Activating ProteinsMembrane ProteinsAnimalsGolgi ApparatusHumansInflammationMiceMice, Inbred C57BLProtonsSignal TransductionSTING ProteinCytokinesGTPase-Activating ProteinsMembrane ProteinsProtonsSting1 protein, mouseSTING Proteinantiviral immunityArfGAP2autoinflammationcGASchemokinescytokinesGolgi traffickinginterferonSAVISTING

Identifiers

PMID39947179
PMCPMC11928284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.